Colorectal Cancer Screening Study
Help us diagnose colorectal cancer with a simple blood draw.
Screening Made Simple
Imagine a day when screening for colorectal cancer is as simple as a blood test. Join the ECLIPSE research study to bring that day forward.
To qualify, you must:
See if you qualify
What is ECLIPSE?
- ECLIPSE is a colorectal cancer screening study to learn if early signs of colorectal cancer can be detected by a simple blood test.
- ECLIPSE is one of the largest cancer screening studies of its kind. It will enroll 12,000 people from across the United States.
Why should I join?
Getting screened is the single best way to prevent colorectal cancer or catch it early, when it can be cured. The American Cancer Society recommends that average-risk adults begin colorectal cancer screening at age 45.
Yet 1 in 3 people in the U.S. are not getting screening with today’s options, which most commonly include colonoscopy and stool-based testing.
A simple blood test like the one being studied in the ECLIPSE study could boost screening rates and help save lives by making screening as simple as a blood draw.